|
|
Article: "Commercial And Pipeline Insight: Allergic Rhinitis" by Datamonitor November 2007.
- Article from:
- M2 Presswire
- Article date:
- November 9, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-9 November 2007-MindBranch: "Commercial And Pipeline Insight: Allergic Rhinitis" by Datamonitor November 2007(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:08112007
Introduction
The allergic rhinitis market will continue to decline over the next few years, after which it will resume limited growth due to the introduction of new compounds and combination products. These will drive the expansion of sales in existing classes as they exhibit safety and convenience advantages. Meanwhile, immunotherapy is expected to move from its niche position into mainstream therapy.
Scope
Indication-based forecasts for allergic rhinitis ...